Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 10Myelodysplastic Syndromes 4Mycoses 4Hematologic Neoplasms 4Leukemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neoplasm, Residual 1Myelodysplastic-Myeloproliferative Diseases 1Mucormycosis 1Leukemia, Myeloid 1Invasive Fungal Infections 1Genetic Predisposition to Disease 1Candidiasis 1Bronchiolitis Obliterans Syndrome 1Bone Marrow Neoplasms 1Bone Marrow Failure Disorders 1Aspergillosis 1Anemia, Aplastic 1

Interventions

Filgrastim 9Cytarabine 7Etoposide 5Cefepime 4Peripheral Blood Stem Cell Transplantation 3Mitoxantrone 3Levofloxacin 3Idarubicin 3Daunorubicin 3Cyclosporine 3Ciprofloxacin 3Caspofungin 3pegfilgrastim 2liposomal amphotericin B 2Thioguanine 2Radiotherapy 2Methotrexate 2Meropenem 2Itraconazole 2Cyclophosphamide 2Ceftazidime 2Amsacrine 2Amoxicillin-Potassium Clavulanate Combination 2sargramostim 1posaconazole 1lintuzumab 1leridistim 1isavuconazole 1fludarabine phosphate 1flt3 ligand protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × posaconazole × Other hematologic neoplasm × Clear all
NCT00686543 2017-04-07

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Merck Sharp & Dohme LLC

Phase 4 Completed
75 enrolled 14 charts
Other hematologic neoplasm

Mycoses, Neutropenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡